Dermatology CRO Market (By Type: Drug Discovery, Preclinical, Clinical; By Service: Project Management/Clinical Supply Management, Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management/Assurance, Bio-statistics, Investigator Payments, Laboratory, Patient and Site Recruitment, Technology) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2023-2032

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Dermatology CRO Market, By Type

7.1.  Dermatology CRO Market, by Type, 2023-2032

7.1.1.    Drug Discovery

7.1.1.1.        Market Revenue and Forecast (2020-2032)

7.1.2.    Preclinical

7.1.2.1.        Market Revenue and Forecast (2020-2032)

7.1.3.    Clinical

7.1.3.1.        Market Revenue and Forecast (2020-2032)

Chapter 8.  Global Dermatology CRO Market, By Services

8.1.  Dermatology CRO Market, by Services, 2023-2032

8.1.1.    Project Management/Clinical Supply Management

8.1.1.1.        Market Revenue and Forecast (2020-2032)

8.1.2.    Data Management

8.1.2.1.        Market Revenue and Forecast (2020-2032)

8.1.3.    Regulatory/Medical Affairs

8.1.3.1.        Market Revenue and Forecast (2020-2032)

8.1.4.    Medical Writing

8.1.4.1.        Market Revenue and Forecast (2020-2032)

8.1.5.    Clinical Monitoring

8.1.5.1.        Market Revenue and Forecast (2020-2032)

8.1.6.    Quality Management/Assurance

8.1.6.1.        Market Revenue and Forecast (2020-2032)

8.1.7.    Bio-statistics

8.1.7.1.        Market Revenue and Forecast (2020-2032)

8.1.8.    Investigator Payments

8.1.8.1.        Market Revenue and Forecast (2020-2032)

8.1.9.    Laboratory

8.1.9.1.        Market Revenue and Forecast (2020-2032)

8.1.10.  Patient and Site Recruitment

8.1.10.1.      Market Revenue and Forecast (2020-2032)

8.1.11.  Technology

8.1.11.1.      Market Revenue and Forecast (2020-2032)

Chapter 9.  Global Dermatology CRO Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Type (2020-2032)

9.1.2.    Market Revenue and Forecast, by Services (2020-2032)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Type (2020-2032)

9.1.3.2.        Market Revenue and Forecast, by Services (2020-2032)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Type (2020-2032)

9.1.4.2.        Market Revenue and Forecast, by Services (2020-2032)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Type (2020-2032)

9.2.2.    Market Revenue and Forecast, by Services (2020-2032)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Type (2020-2032)

9.2.3.2.        Market Revenue and Forecast, by Services (2020-2032)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Type (2020-2032)

9.2.4.2.        Market Revenue and Forecast, by Services (2020-2032)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Type (2020-2032)

9.2.5.2.        Market Revenue and Forecast, by Services (2020-2032)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Type (2020-2032)

9.2.6.2.        Market Revenue and Forecast, by Services (2020-2032)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Type (2020-2032)

9.3.2.    Market Revenue and Forecast, by Services (2020-2032)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Type (2020-2032)

9.3.3.2.        Market Revenue and Forecast, by Services (2020-2032)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Type (2020-2032)

9.3.4.2.        Market Revenue and Forecast, by Services (2020-2032)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Type (2020-2032)

9.3.5.2.        Market Revenue and Forecast, by Services (2020-2032)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Type (2020-2032)

9.3.6.2.        Market Revenue and Forecast, by Services (2020-2032)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Type (2020-2032)

9.4.2.    Market Revenue and Forecast, by Services (2020-2032)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Type (2020-2032)

9.4.3.2.        Market Revenue and Forecast, by Services (2020-2032)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Type (2020-2032)

9.4.4.2.        Market Revenue and Forecast, by Services (2020-2032)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Type (2020-2032)

9.4.5.2.        Market Revenue and Forecast, by Services (2020-2032)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Type (2020-2032)

9.4.6.2.        Market Revenue and Forecast, by Services (2020-2032)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Type (2020-2032)

9.5.2.    Market Revenue and Forecast, by Services (2020-2032)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Type (2020-2032)

9.5.3.2.        Market Revenue and Forecast, by Services (2020-2032)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Type (2020-2032)

9.5.4.2.        Market Revenue and Forecast, by Services (2020-2032)

Chapter 10.  Company Profiles

10.1.              IQVIA HOLDINGS INC.

10.1.1.  Company Overview

10.1.2.  Type Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Covance Inc.

10.2.1.  Company Overview

10.2.2.  Type Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Pharmaceutical Product Development, LLC (PPD)

10.3.1.  Company Overview

10.3.2.  Type Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Parexel International Corporation

10.4.1.  Company Overview

10.4.2.  Type Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Charles River Laboratories International, Inc.

10.5.1.  Company Overview

10.5.2.  Type Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Icon, Plc

10.6.1.  Company Overview

10.6.2.  Type Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Medidata Solutions, Inc.

10.7.1.  Company Overview

10.7.2.  Type Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Syneos Health

10.8.1.  Company Overview

10.8.2.  Type Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Pharmaron

10.9.1.  Company Overview

10.9.2.  Type Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           GVK Biosciences Private Limited

10.10.1.               Company Overview

10.10.2.               Type Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

12.2.              Glossary of Terms